|
Market Closed -
Nasdaq
23:00:00 14/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 26.08 USD | +0.12% |
|
+2.11% | -2.61% |
| 08-18 | Barclays Adjusts Price Target on Amphastar Pharmaceuticals to $23 From $20, Maintains Equalweight Rating | MT |
| 08-07 | Amphastar Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.12% | +2.11% | +9.08% | +38.69% | -2.61% | +9.30% | -43.88% | +35.62% | +44.89% | 1.11B | |
| +3.62% | +1.68% | +6.19% | +4.88% | +12.47% | +48.80% | +96.02% | +410.68% | +1,424.84% | 1,040B | |
| +2.13% | -1.76% | -4.66% | +0.02% | +22.69% | +33.04% | +61.18% | +58.58% | +115.98% | 599B | |
| +3.32% | +4.47% | +8.29% | +15.81% | +24.07% | +23.72% | +92.54% | +160.29% | +371.13% | 485B | |
| +3.80% | +3.21% | +1.74% | +22.02% | +40.01% | +73.99% | +41.51% | +88.14% | +137.16% | 350B | |
| +3.09% | +6.03% | +7.76% | +12.16% | +13.01% | +27.85% | +45.42% | +3.86% | +58.50% | 345B | |
| +2.82% | +4.68% | +9.48% | -1.54% | +11.92% | +17.38% | +40.15% | +60.34% | +64.53% | 272B | |
| +3.40% | +2.86% | +5.06% | -2.46% | -10.80% | -3.33% | +12.08% | +38.90% | +148.46% | 244B | |
| +3.21% | +3.15% | +11.69% | +19.95% | +30.19% | +45.01% | +48.53% | +106.07% | +163.19% | 223B | |
| +3.80% | +4.56% | +4.87% | +18.07% | +25.09% | +29.59% | +93.86% | +125.30% | +111.05% | 183B | |
| -0.27% | +4.24% | -7.42% | -21.10% | -21.31% | -31.48% | -64.28% | -20.51% | +92.66% | 170B | |
| +2.96% | +4.32% | +5.38% | +20.45% | +17.31% | +19.13% | -12.20% | -29.90% | -10.56% | 162B | |
| +2.74% | -1.41% | -4.04% | +4.66% | +9.96% | +20.93% | +33.29% | +174.05% | +529.18% | 123B | |
| +4.61% | -0.70% | -7.52% | +4.09% | +9.90% | +35.34% | +3.69% | +2.74% | +19.11% | 116B | |
| +1.53% | +7.28% | +7.20% | +21.56% | +19.05% | +24.90% | +114.49% | +380.93% | +506.57% | 112B | |
| +1.53% | +1.71% | -1.97% | -6.85% | -13.18% | -14.66% | -30.53% | -14.02% | +5.37% | 94.87B | |
| +3.59% | +2.86% | +2.57% | -7.04% | -0.47% | +11.58% | +20.26% | +3.70% | -14.54% | 93.05B | |
| +4.65% | +15.18% | +54.27% | +235.56% | +667.38% | +762.10% | +146.14% | -31.81% | - | 86.33B | |
| +3.35% | +4.88% | -1.94% | +18.63% | +0.84% | +35.93% | -7.74% | +40.09% | +109.42% | 75.2B | |
| +3.12% | +2.09% | +7.95% | +1.47% | +15.74% | +20.51% | -5.68% | -25.90% | +48.93% | 66.97B | |
| Average | +2.76% | +2.32% | +5.70% | +19.95% | +43.56% | +59.48% | +34.24% | +78.36% | +206.62% | 242.14B | |
| Weighted average by Cap. | +3.11% | +2.23% | +4.64% | +11.39% | +26.80% | +44.13% | +55.46% | +144.20% | +432.81% |
- Stock Market
- Stocks
- AMPH Stock
- Sector Amphastar Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
